Joshua Ellenhorn, MD, FACS

Los Angeles, United States

5

Closed now

2 reviews

By Appointment Only

Map

Streetview

Activate map

Bussiness info

By Appointment Only
Yes
Accepts Insurance
Yes

Description

Specialties

Joshua D.I. Ellenhorn, M.D., FACS, is an accomplished, board-​certified surgical oncologist with a clinical focus on innovative treatments of breast cancer, gastrointestinal metastases, and other types of cancer. He is the Co-​Director of The Breast Center at the Surgery Group of Los Angeles, an accomplished educator, as well, and has been repeatedly recognized nationally for his expertise in surgery.

Dr. Ellenhorn is a respected member of the surgical oncology community. He has given lectures on cancer treatment at prestigious facilities and universities across the country fornearlytwo decades, and is an active member and fellow of several notable surgical societies. Dr. Ellenhornserved as President of the Los Angeles Surgical Society in 2008, is the holder of two patents, and has been ranked in the top 1% of United States surgeons by U.S. News and World Report since 2011.

Meet the Business Owner

Dr. Joshua Ellenhorn.

Business Owner

Joshua D.I. Ellenhorn, M.D., FACS, is an accomplished, board-​certified surgical oncologist with a clinical focus on innovative treatments of breast cancer, gastrointestinal metastases, and other types of cancer. He is the Co-​Director of The Breast Center at the Surgery Group of Los Angeles, an accomplished educator, as well, and has been repeatedly recognized nationally for his expertise in surgery.

Dr. Ellenhorn is a respected member of the surgical oncology community. He has given lectures on cancer treatment at prestigious facilities and universities across the country fornearlytwo decades, and is an active member and fellow of several notable surgical societies. Dr. Ellenhornserved as President of the Los Angeles Surgical Society in 2008, is the holder of two patents, and has been ranked in the top 1% of United States surgeons by U.S. News and World Report since 2011.